ECSS
EXAS

Eurizon Capital SGR SpA’s Exact Sciences EXAS Stock Holding History

Eurizon Capital SGR SpA’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,578
Closed -$364K – 1228
2025
Q4 		$364K Buy
+3,578
New +$287K ﹤0.01% 603

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Eurizon Capital SGR SpA's EXAS Position: Q1 2026 in Review

Eurizon Capital SGR SpA sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 3,578 shares — an estimated $364K sold.

Eurizon Capital SGR SpA first reported a position in EXAS in Q4 2025 and held it in 1 quarter. The position peaked at $364K in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Eurizon Capital SGR SpA reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Eurizon Capital SGR SpA sold 3,578 Exact Sciences shares in Q1 2026, an estimated $364K.
  • Eurizon Capital SGR SpA first reported a position in Exact Sciences in Q4 2025 and held it in 1 quarter.
  • Eurizon Capital SGR SpA's Exact Sciences position peaked at $364K in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Eurizon Capital SGR SpA's 13F filing for Q1 2026, filed 8 May 2026.